RNA splicing factors regulated by HPV16 during cervical tumour progression

Journal of Pathology

Volumn 219, Issue 3, 2009, Pages 383-391

  Mole, Sarah ^a   McFarlane, Melanie ^a   Chuen Im, Thanaporn ^a   Milligan, Steven G ^a,c   Millan, David ^b,d   Graham, Sheila V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c University of Silpakorn   (Thailand)

^d GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Cervix; CIN; HPV16 E2; Human papillomavirus type 16; Immunohistochemistry; SF2 ASF; SR proteins

Indexed keywords

ONCOPROTEIN; PROTEIN ASF; PROTEIN E 2; PROTEIN SF 2; PROTEIN SR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; KERATINOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; UPREGULATION; UTERINE CERVIX TUMOR; WILD TYPE;

DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; RNA SPLICING; RNA, NEOPLASM; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 70350449105     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2608     Document Type: Article

References (35)

1. Howley PM. Papillomavirinae: the viruses and their replication. In Fields' Virology, Fields BN, Knipe DN, Howley PM (eds). Lippincott-Raven: Philadelphia, PA, 1996; 2045-2076.
2. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004;68:362-372.
3. Stanley MA. Immunobiology of papillomavirus infections. J Reprod Immunol 2001;52:45-59.
4. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350. (Pubitemid 37328947)
5. Morgan IM, Donaldson MM. The papillomavirus transcription/replication factor E2: structure, function, cancer and therapy. In Papillomavirus Research: From Natural History to Vaccines and Beyond, Campo MS (ed.). Caister Academic: Wymondham, Norfolk, 2006; 73-82.
6. Wang G-S, Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 2007;8:749-761.
7. Long JC, Caceres JF. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009;417:15-27.
8. Sanford JR, Ellis J, Caceres JF. Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem Soc Trans 2005;33:443-446. (Pubitemid 40873861)
9. Mole S, Milligan SG, Graham SV. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J Virol 2009;83:357-367.
10. McPhillips MG, Veerapraditsin T, Cumming SA, Karali D, Milligan SG, Boner W, et al. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during epithelial differentiation. J Virol 2004;78:10598-10605. (Pubitemid 39258386)
11. Fay J, Kelehan P, Lambkin H, Schwartz S. Increase expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J Med Virol 2009;81:897-907.
12. Fuchs E, Byrne C. The epidermis: rising to the surface. Curr Biol 1994;4:725-736.
13. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Hum Pathol 1992;23:117-128.
14. Milligan SG, Veerapraditsin T, Ahamat B, Mole S, Graham SV. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 2007;360: 172-181. (Pubitemid 46335715)
15. Jeon S, Allen-Hoffman BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995;69:2989-2997.
16. Aasen T, Hodgins MB, Edward M, Graham SV. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression. Oncogene 2003;22:7969-7980. (Pubitemid 37175862)
17. Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992;257:971-973.
18. Stanley MA, Browne HM, Appelby M, Minson AC. Properties of a non-tumourigenic human cervical keratinocyte cell line. Int J Cancer 1989;43:672-676.
19. Chuen-Im T, Zhang J, Milligan SG, McPhillips MG, Graham SV. The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res 2008;131:189-198. (Pubitemid 351192950)
20. Boukamp P, Petrussevska RT, Breitkreutz R, Horhung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalised aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-771. (Pubitemid 18089976)
21. Hanamura A, Càceres JF, Mayeda A, Franza BR, Krainer AR. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 1998;4:430-444.
22. Taylor ER, Boner W, Dornan ES, Corr EM, Morgan IM. UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein. Oncogene 2003;22:4469-4477. (Pubitemid 36920690)
23. Parish JL, Kowalczyk A, Chen HT, Roeder GE, Sessions R, Buckle M, et al. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol 2006;80:4580-4590.
24. Tang S, Tao M, McCoy JP, Zheng Z-M. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 2006;80:4249-4263.
25. Mole S, Veerapraditsin T, McPhillips M, Graham SV. Regulation of splicing-associated SR proteins by HPV16. Biochem Soc Trans 2006;34:1145-1147.
26. Beyer-Finkler E, Stoler MH, Girardi F, Pfister HJ. Cell differentiation-related gene expression of human papillomavirus 33. Med Microbiol Immunol 1990;179:185-192. (Pubitemid 20343615)
27. Hummel M, Hudson JB, Laimins LA. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 1992;66:6070-6080.
28. Maitland NJ, Conway S, Wilkinson NS, Ramsdale J, Morris JR, Sanders CM, et al. Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J Pathol 1998;186:275-280. (Pubitemid 28494355)
29. Stevenson M, Hudson LC, Burns JE, Stewart RL, Wells M, Maitland NJ. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J Gen Virol 2000;81:1825-11823 (Pubitemid 30427089)
30. Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C, et al. Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 2009;83:167-180.
31. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR. The gene encoding the splicing factor SF2/ASF is a protooncogene. Nat Struct Mol Biol 2007;14:185-193. (Pubitemid 46355578)
32. Fischer DC, Noack K, Runnebaum IB, Watermann DO, Kieback DG, Stamm S, et al. Expression of splicing factors in human ovarian cancer. Oncol Rep 2004;11:1085-1090.
33. Stickeler E, Kittrell F, Medina D, Berget S. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999;18:3574-3582. (Pubitemid 29322382)
34. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G. Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 1998;58:5818-5824. (Pubitemid 29006424)
35. Karni R, Hippo Y, Lowe SW, Krainer AR. The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci USA 2008;105:15323-15327.